Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Director Compensation Fiscal 2005-2007...

It's apparent that if one were to research just the option grants to our employees and directors over the past 10 years that Swartz isn't the only gorilla in the room when it comes to our 391 million shares.

Yes...I realize this is the OTCBB and that many risks are involved but as a long term holder and believer in our patented technology do we really have the power (or the stamina) to make needed changes?

At this point, I'm just wondering out loud if in fact we can make this a successful viable company long term or will we continue to operate as a trading instrument. The past weeks have been gut wrenching for all of us...I want nothing more then to exceed and stabilize around or even past those levels we saw in March, 2006 (or for those who have been here...in January, 2000).

Go PTSC Onwards and Upwards!

Cheers~

Share
New Message
Please login to post a reply